Stockreport

HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program [Yahoo! Finance]

HCW Biologics Inc.  (HCWB) 
PDF that were well tolerated at a level significantly higher than the identified efficacious dose level Program has addressed key challenges for first generation T-cell en [Read more]